ANI
25 Jan 2020, 19:33 GMT+10
London [UK], Jan 25 (ANI): A recent study has pointed towards the presence of racial disparities in the medical care provided to dementia patients.
The University College of London (UCL) led research inferred from its findings that dementia patients from black and Asian communities in the UK are deprived of the same quality of treatment which is available to their white counterparts.
The finding which was published in Clinical Epidemiology, reveal that Asian people with dementia are less likely to receive anti-dementia drugs, and they take them for shorter periods.
People belonging to black ethnic groups who are diagnosed with dementia are prescribed antipsychotic drugs. Not giving attention to the primary symptoms, they are being suggested drugs that are used to treat dementia-related distress.
The lead author of the study, Professor Claudia Cooper said, "Our new findings are concerning as they appear to reflect inequalities in the care people receive to treat symptoms associated with dementia."Researchers analysed data from 53,718 people across the UK who had a dementia diagnosis, and 1,648,889 people without dementia, drawing from The Health Improvement Network primary care database and collected between 2014 and 2016.
Analysed a data of 53,718 people across the UK who had a dementia diagnosis, and 1,648,889 people without dementia, the researchers found that, Asian people with dementia were 14 per cent less likely than white patients to be prescribed anti-dementia drugs when they were potentially beneficial, and received them for an average of 15 fewer days per year.
Drugs like antipsychotics are usually prescribed to treat some of the associated and psychological symptoms, while, Anti-dementia drugs - cholinesterase inhibitors or memantine - are the only class of medication available for treating dementia.
Both Asian and black people with dementia were prescribed antipsychotic drugs for longer than white patients, by 27 and 17 days more, respectively, which could put them at greater risk of harmful side effects.
"Rates of antipsychotic prescribing in all ethnic groups exceeded recommendations for treating the often very distressing behavioural and psychological symptoms of dementia, such as agitation or challenging behaviours, which are the most common reasons antipsychotic drugs are prescribed to people living with dementia," explained Professor Cooper.
Co-author professor Jill Manthorpe also pitched that health experts should raise the question of whether antipsychotic drugs are being prescribed instead of other forms of support that could address causes of the distressing symptoms. (ANI)Get a daily dose of Asia Pacific Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Asia Pacific Star.
More InformationDHARAMSHALA, India: The Dalai Lama is set to address a significant three-day conference of Buddhist leaders this week, coinciding with...
BEIJING, China: China's national soccer team may struggle to stir excitement, but its humanoid robots are drawing cheers — and not...
]LONDON, U.K.: A World Health Organization (WHO) expert group investigating the origins of the COVID-19 pandemic released its final...
FRANKFURT, Germany: Germany has become the latest country to challenge Chinese AI firm DeepSeek over its data practices, as pressure...
Nearly three months after a devastating earthquake struck Myanmar, the country remains trapped in a deepening crisis, compounded by...
Moscow seeks to build a full-fledged partnership, according to its ambassador in Kabul Moscow has officially recognized the Taliban...
NEW YORK, New York -U.S. stock markets closed with broad gains on Thursday, led by strong performances in U.S. tech stocks, while European...
LONDON/STOCKHOLM: The Persson family is ramping up its investment in the H&M fashion empire, fueling renewed speculation about a potential...
PARIS, France: L'Oréal is making a fresh play in the booming premium haircare segment with a new acquisition. The French beauty conglomerate...
MENLO PARK, California: Robinhood is giving European investors a new way to tap into America's most prominent tech names — without...
NEW YORK, New York - U.S. stocks diverged on Wednesday for the second day in a row. The Standard and Poor's 500 hit a new all-time...
NEW YORK CITY, New York: The U.S. dollar continues to lose ground, weighed down by growing concerns over Washington's fiscal outlook...